Homozygous deletion of the CYP21A-TNXA-RP2-C4B gene region conferring C4B deficiency associated with recurrent respiratory infections

Human Immunology

Volumn 60, Issue 8, 1999, Pages 707-714

  Jaatinen, Taina ^a   Ruuskanen, Olli ^b   Truedsson, Lennart ^c   Lokki, Marja Liisa ^a  

^a Tissue Typing Laboratory   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Complement C4; Deficiency; Deletion; Infection; MHC

Indexed keywords

COMPLEMENT COMPONENT C4B;

ARTICLE; CASE REPORT; COMPLEMENT DEFICIENCY; GENE DELETION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; VIRUS PNEUMONIA;

ADULT; CHILD, PRESCHOOL; COMPLEMENT C4B; FAMILY; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; MALE; NUCLEAR PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECURRENCE; RESPIRATORY TRACT INFECTIONS; STEROID 21-HYDROXYLASE; TENASCIN;

EID: 0032807544     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00047-6     Document Type: Article

References (48)

1. Dangel A.W., Mendoza A.R., Baker B.J., Daniel C.M., Carroll M.C., Wu L.C., Yu C.Y. The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics. 40:1994;425.
2. Chu X., Rittner C., Schneider P.M. Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. Exp Clin Immunogenet. 12:1995;74.
3. Tassabehji M., Strachan T., Anderson M., Campbell R.D., Collier S., Lako M. Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. Nucleic Acids Res. 22:1994;5211.
4. Gitelman S.E., Bristow J., Miller W.L. Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. Mol Cell Biol. 12:1992;2124.
5. Shen L., Wu L.C., Sanlioglu S., Chen R., Mendoza A.R., Dangel A.W., Carroll M.C., Zipf W.B., Yu C.Y. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication . J Biol Chem. 269:1994;8466.
6. Yang Z, Mendoza AR, Welch WT, Zipf W, Yu CY: Modular variations of the human MHC class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21 and tenascin TNX (RCCX): a mechanism for gene deletions and disease associations. (Submitted).
7. Campbell R.D., Dunham I., Kendall E., Sargent C.A. Polymorphism of the human complement component C4. Expl Clin Immunogenet. 7:1990;69.
8. White P.C., New M.I., Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci. 83:1986;5111.
9. Speek M., Barry F., Miller W.L. Alternate promoters and alternate splicing of human tenascin-X, a gene with 5′ and 3′ ends buried in other genes. Hum Mol Genet. 5:1996;1749.
10. Burch G.H., Gong Y., Liu W., Dettman R.W., Curry C.J., Smith L., Miller W.L., Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet. 17:1997;104.
11. Schneider P.M., Carroll M.C., Alper C.A., Rittner C., Whitehead A.S., Yunis E.J., Colten H.R. Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. J Clin Invest. 78:1986;650.
12. Fremeaux-Bacchi V., Uring-Lambert B., Weiss L., Brun P., Blouin J., Hartmann D., Loirat C., Hauptmann G., Kazatchkine M.D. Complete inherited deficiency of the fourth complement component in a child with systemic lupus erythematosus and his disease-free brother in a north African family. J Clin Immunol. 14:1994;273.
13. Franciotta D., Dondi E., Bergamaschi R., Piccolo G., d'Eril G.M., Cosi V., Cuccia M. HLA complement gene polymorphisms in multiple sclerosis. A study on 80 Italian patients. J Neurol. 242:1995;64.
14. Venneker G.T., Westerhof W., de Vries I.J., Drayer N.M., Wolthers B.G., de Waal L.P., Bos J.D., Asghar S.S. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. J Invest Dermatol. 99:1992;853.
15. Sacks S.H., Nomura S., Warner C., Naito S., Ogahara S., Vaughan R., Briggs D. Analysis of complement C4 loci in Caucasoids and Japanese with idiopathic membranous nephropathy. Kidney Int. 42:1992;882.
16. Yu C.Y., Campbell R.D. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants application to the study of C4 null alleles . Immunogenetics. 25:1987;383.
17. Martínez-Quiles N., Paz-Artal E., Moreno-Pelayo M.A., Longás J., Ferre-López S., Rosal M., Arnaiz-Villena A. C4d DNA sequences of two infrequent human allotypes (C4A13 and C4B12) and the presence of signal sequences enhancing recombination. J Immunol. 161:1998;3438.
18. Lokki M.L., Circolo A., Ahokas P., Rupert K.L., Yu C.Y., Colten H.R. Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes. J Immunol. 162:1999;3687.
19. Rupert KL, Rennebohm RM, Yu CY: An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis. Exp Clin Immunogenet (in press).
20. Yu C.Y. Molecular genetics of the human MHC complement gene cluster. Exp Clin Immunogenet. 15:1998;213.
21. Amos D.B., Bashir H., Boyle W., MacQueen M., Tiilikainen A. A simple microcytotoxicity test. Transplantation. 7:1969;220.
22. Marcus D., Alper C.A. Methods for allotyping complement proteins. Rose N.R., Friedman H., Fahey J.L. Manual of Clinical Laboratory Immunology 1986. 1986;American Association for Microbiology, Washington, DC.
23. Sim E., Cross S.J. Phenotyping of human complement component C4, a class-III HLA antigen. Biochem J. 239:1986;763.
24. Jahn I., Mejia J.E., Thomas M., Darke C., Schroder H., Geserick G., Hauptmann G. Genomic analysis of the F subtypes of human complement factor B. Eur J Immunogenet. 21:1994;415.
25. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
26. Belt K.T., Carroll M.C., Porter R.R. The structural basis of the multiple forms of human complement component. Cell. 36:1984;907.
27. Wang X., Circolo A., Lokki M.L., Shackelford P.G., Wetsel R.A., Colten H.R. Molecular heterogeneity in deficiency of complement protein C2 type I. Immunology. 93:1998;184.
28. Levo A., Partanen J. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles. Hum Genet. 99:1997;488.
29. Wedell A., Luthman H. Steroid 21-hydroxylase deficiency two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations . Hum Mol Genet. 2:1993;499.
30. Johnson C.A., Densen P., Hurford R.K. Jr, Colten H.R., Wetsel R.A. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem. 267:1992;9347.
31. Wetsel R.A., Kulics J., Lokki M.L., Kiepiela P., Akama H., Johnson C.A., Densen P., Colten H.R. Type II human complement C2 deficiency. Allele-specific amino acid substitutions (Ser 189 → Phe; Gly444 → Arg) cause impaired C2 secretion. J Biol Chem. 271:1996;5824.
32. Figueroa J.E., Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 4:1991;359.
33. Sissons J.G., Oldstone M.B., Schreiber R.D. Antibody independent inactivation of the alternative complement pathway my measles virus-infected cells. Proc Natl Acad Sci. 77:1980;559.
34. Ehrnst A. Separate pathways of complement activation by measles virus cytotoxic antibodies subclass analysis and capacity of F(ab) molecules to activate complement via the alternative pathway . J Immunol. 121:1978;1206.
35. Fischer M.B., Ma M., Goerg S., Zhou X., Xia J., Finco O., Han S., Kelsoe G., Howard R.G., Rothstein T.L., Kremmer E., Rosen F.S., Carroll M.C. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol. 157:1996;549.
36. Ochs H.D., Wedgwood R.J., Frank M.M., Heller S.R., Hosea S.W. The role of complement in the induction of antibody responses. Clin Exp Immunol. 53:1983;208.
37. Stahel P.F., Nadal D., Pfister H.W., Paradisis P.M., Barnum S.R. Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis [letter]. Lancet. 349:1997;1886.
38. Gendi N.S., Gibson K., Wordsworth B.P. Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis one year follow up of an outbreak . Ann Rheum Dis. 55:1996;63.
39. Gadjeva M., Dodds A.W., Taniguchi-Sidle A., Willis A.C., Isenman D.E., Law S.K.A. The covalent binding reaction of complement component C3. J Immunol. 161:1998;985.
40. Rowe P.C., McLean R.H., Wood R.A., Leggiadro R.J., Winkelstein J.A. Association of homozygous C4B deficiency with bacterial meningitis. J Infect Dis. 160:1989;448.
41. Bishof N.A., Welch T.R., Beischel L.S. C4B deficiency a risk factor for bacteremia with encapsulated organisms . J Infect Dis. 162:1990;248.
42. Cates K.L., Densen P., Lockman J.C., Levine R.P. C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria. J Infect Dis. 165:1992;942.
43. Ekdahl K., Truedsson L., Sjöholm A.G., Braconier J.H. Complement analysis in adult patients with a history of bacteremic pneumococcal infections or recurrent pneumonia. Scand J Infect Dis. 27:1995;111.
44. Nityanand S., Dawkins R.L., Lithell H., Holm G., Lefvert A.K. C4 null alleles in a Swedish population. Eur J Immunogenet. 22:1995;435.
45. Simon S., Truedsson L., Marcus-Bagley D., Awdeh Z., Eisenbarth G.S., Brink S.J., Yunis E.J., Alper C.A. Relationship between protein complotypes and DNA variant haplotypes complotype-RFLP constellations (CRC) . Hum Immunol. 57:1997;27.
46. Lim M., Chan S.H. C4 and 21-hydroxylase gene deletions in nasopharyngeal carcinoma among the Chinese. Ann Acad Med Singapore. 25:1996;42.
47. Weissensteiner T., Lanchbury J.S. Allelic polymorphism of two multifunctional regions in the central human MHC tenascin X, XB-S and YB, and their duplicated fragments XA and YA . Eur J Immunogenet. 24:1997;201.
48. Tee M.K., Babalola G.O., Aza-Blanc P., Speek M., Gitelman S.E., Miller W.L. A promoter within intron 35 of the human C4A gene initiates abundant adrenal-specific transcription of a 1 kb RNA location of a cryptic CYP21 promoter element? Hum Mol Genet. 4:1995;2109.